Standardizing computed tomographic assessment of the mesopancreas in pancreatic cancer patients

Versteijne E, Suker M, Groothuis K, Akkermans-Vogelaar JM, Besselink MG, Bonsing BA, et al. Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial. J Clin Oncol. 2020;38(16):1763–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Versteijne E, van Dam JL, Suker M, Janssen QP, Groothuis K, Akkermans-Vogelaar JM, et al. Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial. J Clin Oncol. 2022;40(11):1220–30.

Article  CAS  PubMed  Google Scholar 

Augustinus S, Schafrat PJM, Janssen BV, Bonsing BA, Brosens LAA, Busch OR, et al. Nationwide Impact of Centralization, Neoadjuvant Therapy, Minimally Invasive Surgery, and Standardized Pathology Reporting on R0 Resection and Overall Survival in Pancreatoduodenectomy for Pancreatic Cancer. Ann Surg Oncol. 2023;30(8):5051–60.

Article  PubMed  PubMed Central  Google Scholar 

Lee YS, Lee J-C, Yang SY, Kim J, Hwang J-H. Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer according to intention-to-treat and per-protocol analysis: A systematic review and meta-analysis. Scientific reports. 2019;9(1):15662.

Article  PubMed  PubMed Central  Google Scholar 

Dhir M, Malhotra GK, Sohal DPS, Hein NA, Smith LM, O’Reilly EM, et al. Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients. World journal of surgical oncology. 2017;15(1):183.

Article  PubMed  PubMed Central  Google Scholar 

Strobel O, Hank T, Hinz U, Bergmann F, Schneider L, Springfeld C, et al. Pancreatic Cancer Surgery: The New R-status Counts. Annals of surgery. 2017;265(3):565–73.

Article  PubMed  Google Scholar 

Isaji S, Mizuno S, Windsor JA, Bassi C, Fernández-Del Castillo C, Hackert T, et al. International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017. Pancreatology: official journal of the International Association of Pancreatology (IAP) [et al]. 2018;18(1):2–11.

Article  PubMed  Google Scholar 

Esposito I, Kleeff J, Bergmann F, Reiser C, Herpel E, Friess H, et al. Most pancreatic cancer resections are R1 resections. Ann Surg Oncol. 2008;15(6):1651–60.

Article  PubMed  Google Scholar 

Bockhorn M, Uzunoglu FG, Adham M, Imrie C, Milicevic M, Sandberg AA, et al. Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2014;155(6):977–88.

Article  PubMed  Google Scholar 

Safi SA, Haeberle L, Fluegen G, Lehwald-Tywuschik N, Krieg A, Keitel V, et al. Mesopancreatic excision for pancreatic ductal adenocarcinoma improves local disease control and survival. Pancreatology: official journal of the International Association of Pancreatology (IAP) [et al]. 2021.

Book  Google Scholar 

Safi SA, David S, Haeberle L, Vaghiri S, Luedde T, Roderburg C, et al. Most oncological pancreas resections must consider the mesopancreas. BMC Cancer. 2025;25(1):200.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Testut L. Traite D‘ Anatomie Humaine. 1923.

Rouviere H. Anatomie Humaine Tome 1 Tete, cou et tronc. 1924.

Langer C. Lehrbuch der Anatomie des Menschen: Wilhelm Braumüller K. K. Hofbuchhaendler; 1865.

Fortner JG, Kim DK, Cubilla A, Turnbull A, Pahnke LD, Shils ME. Regional pancreatectomy: en bloc pancreatic, portal vein and lymph node resection. Annals of surgery. 1977;186(1):42–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Büchler MW. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. The British journal of surgery. 2004;91(5):586–94.

Article  CAS  PubMed  Google Scholar 

Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation–technical notes and outcome. Colorectal disease: the official journal of the Association of Coloproctology of Great Britain and Ireland. 2009;11(4):354–64; discussion 64 – 5.

Article  CAS  PubMed  Google Scholar 

Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet (London, England). 1986;1(8496):1479–82.

Article  CAS  PubMed  Google Scholar 

McAnena OJ, Heald RJ, Lockhart-Mummery HE. Operative and functional results of total mesorectal excision with ultra-low anterior resection in the management of carcinoma of the lower one-third of the rectum. Surgery, gynecology & obstetrics. 1990;170(6):517–21.

CAS  Google Scholar 

Safi SA, Haeberle L, Rehders A, Fung S, Vaghiri S, Roderburg M, et al. Neoadjuvant Treatment Lowers the Risk of Mesopancreatic Fat Infiltration and Local Recurrence in Patients with Pancreatic Cancer. Cancers. 2021.

Safi SA, Haeberle L, Heuveldop S, Kroepil P, Fung S, Rehders A, et al. Pre-Operative MDCT Staging Predicts Mesopancreatic Fat Infiltration-A Novel Marker for Neoadjuvant Treatment? Cancers. 2021;13(17).

Navez J, Pezzullo M, Bouchart C, Arsenijevic T, Demetter P, Closset J, et al. Impact of the radiological morphology of the mesopancreas on the outcome after pancreatoduodenectomy for pancreatic ductal adenocarcinoma: retrospective study. BJS Open. 2024;8(6).

Wellner UF, Krauss T, Csanadi A, Lapshyn H, Bolm L, Timme S, et al. Mesopancreatic Stromal Clearance Defines Curative Resection of Pancreatic Head Cancer and Can Be Predicted Preoperatively by Radiologic Parameters: A Retrospective Study. Medicine (Baltimore). 2016;95(3):e2529.

Article  PubMed  PubMed Central  Google Scholar 

Kimura W. Surgical anatomy of the pancreas for limited resection. Journal of hepato-biliary-pancreatic surgery. 2000;7(5):473–9.

Article  CAS  PubMed  Google Scholar 

Häberle L, Esposito I. Circumferential resection margin (CRM) in pancreatic cancer. Surgery in Practice and Science. 2020;1:100006.

Article  Google Scholar 

Haeberle L, Esposito I. Pathology of pancreatic cancer. Translational gastroenterology and hepatology. 2019;4:50.

Article  PubMed  PubMed Central  Google Scholar 

Menon KV, Gomez D, Smith AM, Anthoney A, Verbeke CS. Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP). HPB: the official journal of the International Hepato Pancreato Biliary Association. 2009;11(1):18–24.

Article  PubMed  PubMed Central  Google Scholar 

Verbeke CS, Leitch D, Menon KV, McMahon MJ, Guillou PJ, Anthoney A. Redefining the R1 resection in pancreatic cancer. The British journal of surgery. 2006;93(10):1232–7.

Article  CAS  PubMed  Google Scholar 

Safi SA, Alexander A, Neuhuber W, Haeberle L, Rehders A, Luedde T, et al. Defining distal splenopancreatectomy by the mesopancreas. Langenbecks Arch Surg. 2024;409(1):127.

Article  PubMed  PubMed Central  Google Scholar 

Ruppert R, Junginger T, Kube R, Strassburg J, Lewin A, Baral J, et al. Risk-Adapted Neoadjuvant Chemoradiotherapy in Rectal Cancer: Final Report of the OCUM Study. J Clin Oncol. 2023;41(24):4025–34.

Article  CAS  PubMed  Google Scholar 

Taylor FG, Quirke P, Heald RJ, Moran B, Blomqvist L, Swift I, et al. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg. 2011;253(4):711–9.

Article  PubMed  Google Scholar 

Schrag D, Shi Q, Weiser MR, Gollub MJ, Saltz LB, Musher BL, et al. Preoperative Treatment of Locally Advanced Rectal Cancer. N Engl J Med. 2023;389(4):322–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matsumoto S, Mori H, Kiyonaga M, Sai M, Yamada Y, Hijiya N, et al. “Peripancreatic strands appearance” in pancreatic body and tail carcinoma: evaluation by multi-detector CT with pathological correlation. Abdominal Imaging. 2012;37(4):602–8.

Article  PubMed  Google Scholar 

Endo Y, Noda H, Iseki M, Aizawa H, Inoue K, Maeda S, et al. Thick mesopancreas is a novel predictor of surgical outcomes of patients who undergo pancreaticoduodenectomy. Langenbeck’s archives of surgery. 2024;409(1):181.

Article  PubMed  Google Scholar 

Comments (0)

No login
gif